Managed competition in health care and the unfinished agenda.
作者信息
Enthoven A C
出版信息
Health Care Financ Rev. 1986;1986(Spec No):105-19.
Abstract
A market made up of health care financing and delivery plans and individual consumers, without a carefully drawn set of rules to mitigate market failures, and without mediation by collective action on the demand side, cannot produce efficiency and equity. The concept of competition that can achieve these goals, at least to a satisfactory approximation, is managed competition, with intelligent active agents on the demand side, called sponsors, that contract with the competing health care plans and continuously structure and adjust the market to overcome its tendencies to failure. A great deal remains to be done to achieve the goals envisioned by the "procompetition reformers."
摘要
相似文献
1
Managed competition in health care and the unfinished agenda.
Health Care Financ Rev. 1986;1986(Spec No):105-19.
2
Managed competition of alternative delivery systems.
J Health Polit Policy Law. 1988 Summer;13(2):305-21. doi: 10.1215/03616878-13-2-305.
3
A free market in health care.
Lancet. 1988 May 28;1(8596):1210-4. doi: 10.1016/s0140-6736(88)92021-1.
4
From the Office of the General Counsel. When health care payers have market power.
JAMA. 1990 Apr 11;263(14):1981-2, 1986.
5
Market responses to HMOs: price competition or rivalry?
Inquiry. 1988 Summer;25(2):207-18.
6
Competition among health insurers, revisited.
J Health Polit Policy Law. 1988 Summer;13(2):279-91. doi: 10.1215/03616878-13-2-279.
7
Can HMOs wield market power? Assessing antitrust liability in the imperfect market for health care financing.
Am Univ Law Rev. 1996 Oct;46(1):91-147.
8
Competition in hospital and health insurance markets: a review and research agenda.
Health Serv Res. 2001 Apr;36(1 Pt 2):191-221.
9
On the ideal market structure for third-party purchasing of health care.
Soc Sci Med. 1994 Nov;39(10):1413-24. doi: 10.1016/0277-9536(94)90236-4.
10
Medical competition shouldn't be lethal.
JAMA. 1985 Nov 15;254(19):2799-800.
引用本文的文献
1
Barriers and facilitators to providing common preventive screening services in managed care settings.
J Community Health. 1999 Jun;24(3):229-47. doi: 10.1023/a:1018765532250.
2
The strange career of managed competition: from military failure to medical success?
Am J Public Health. 1994 Mar;84(3):482-9. doi: 10.2105/ajph.84.3.482-a.
3
The effect of the illness episode approach on Medicare beneficiaries' health insurance decisions.
Health Serv Res. 1992 Dec;27(5):671-93.
4
[Learning from America?--Managed Health Care, experiences in health cost containment exemplified by Medicaid in Massachusetts, USA].
Soz Praventivmed. 1992;37(1):6-12. doi: 10.1007/BF01369096.
本文引用的文献
1
Medicare capitation payments to HMOs in light of regression toward the mean in health care costs.
Adv Health Econ Health Serv Res. 1985;6:75-100.
2
Pre-enrollment reimbursement patterns of Medicare beneficiaries enrolled in "at-risk" HMOs.
Health Care Financ Rev. 1982 Sep;4(1):55-73.
3
Risk differential between Medicare beneficiaries enrolled and not enrolled in an HMO.
Health Care Financ Rev. 1980 Winter;1(3):91-9.
4
Risk adjusting health care outcomes: a methodologic review.
Med Care Rev. 1986 Fall;43(2):351-93. doi: 10.1177/107755878604300205.
5
Buying right: the consequences of glut.
Bus Health. 1985 Sep;2(9):43-6.
6
"Free choice" as a restraint of trade in American health care delivery and insurance.
Spec Law Dig Health Care (Mon). 1985 May;7(3):5-46.
7
Using competition to develop a buyer driven market.
Bus Health. 1985 Nov;3(1):39-42.
8
Buying right: how to do it.
Bus Health. 1985 Oct;2(10):41-4.
9
Is cream-skimming a problem for the competitive medical market?
J Health Econ. 1984 Apr;3(1):87-95. doi: 10.1016/0167-6296(84)90029-8.
10
Is competition the answer?
J Health Econ. 1982 May;1(1):110-6. doi: 10.1016/0167-6296(82)90023-6.
Zotero 插件